Holen Sie sich die Stockscreener-App
4.00
2.68%
-0.11
Handel nachbörslich:
4.00
Schlusskurs vom Vortag:
$4.11
Offen:
$4.2
24-Stunden-Volumen:
1.89M
Relative Volume:
1.02
Marktkapitalisierung:
$689.65M
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-1.4286
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
+8.40%
1M Leistung:
+9.59%
6M Leistung:
+25.39%
1J Leistung:
-37.01%
1-Tages-Spanne:
$3.915
$4.26
1-Wochen-Bereich:
$3.52
$4.26
52-Wochen-Spanne:
$1.775
$10.72
Relay Therapeutics Inc Stock (RLAY) Company Profile
Firmenname
Relay Therapeutics Inc
Sektor
Branche
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Vergleichen Sie RLAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
4.00 | 631.03M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-10 | Fortgesetzt | Goldman | Buy |
| 2024-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-04-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Eingeleitet | Raymond James | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-09-30 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-02 | Eingeleitet | Stifel | Buy |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-07-21 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-10 | Eingeleitet | Cowen | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Guggenheim | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Tools to assess Relay Therapeutics Inc.’s risk profileJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
What candlestick patterns are forming on Relay Therapeutics Inc.CPI Data & Weekly Breakout Watchlists - Newser
Published on: 2025-09-03 06:45:04 - Newser
What MACD signals say about Relay Therapeutics Inc.Trade Risk Summary & Reliable Entry Point Trade Alerts - Newser
Can Relay Therapeutics Inc. hit a new high this monthMarket Trend Summary & Fast Momentum Stock Entry Tips - Newser
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary - GlobeNewswire Inc.
News impact scoring models applied to Relay Therapeutics Inc.Quarterly Investment Review & AI Enhanced Execution Alerts - Newser
Is Relay Therapeutics Inc. still worth holding after the dip2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Relay Therapeutics Inc. stock daily chart insightsPortfolio Return Report & Smart Money Movement Alerts - Newser
Heatmap analysis for Relay Therapeutics Inc. and competitorsJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
Will a bounce in Relay Therapeutics Inc. offer an exitMarket Rally & Weekly Stock Performance Updates - Newser
Pattern recognition hints at Relay Therapeutics Inc. upsideMarket Performance Summary & Proven Capital Preservation Tips - Newser
Will Relay Therapeutics Inc. price bounce be sustainable2025 Top Decliners & Entry Point Confirmation Alerts - Newser
Will earnings trigger a reversal in Relay Therapeutics Inc.Dollar Strength & High Conviction Investment Ideas - Newser
Real time breakdown of Relay Therapeutics Inc. stock performance2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - Newser
Comparing Relay Therapeutics Inc. in custom built stock radarsGap Up & Free Expert Approved Momentum Trade Ideas - Newser
Can Relay Therapeutics Inc. sustain its profitability2025 Retail Activity & Stepwise Swing Trade Plans - khodrobank.com
Volume spikes in Relay Therapeutics Inc. stock – what they meanShare Buyback & Verified Momentum Stock Ideas - Newser
Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com
Is Relay Therapeutics Inc. a cyclical or defensive stockJuly 2025 Breakouts & Low Drawdown Investment Strategies - khodrobank.com
Traders Consider Averaging Down in Relay Therapeutics Inc. getLinesFromResByArray error: size == 0 - news-j.co.kr
Momentum divergence signals in Relay Therapeutics Inc. chart2025 Market Sentiment & Risk Managed Trade Strategies - Newser
What’s the recovery path for long term holders of Relay Therapeutics Inc.July 2025 Review & Real-Time Chart Breakout Alerts - Newser
Why Relay Therapeutics Inc. is moving todayQuarterly Market Review & Daily Price Action Insights - Newser
How moving averages guide Relay Therapeutics Inc. tradingEntry Point & Long-Term Safe Investment Plans - Newser
Advanced analytics toolkit walkthrough for Relay Therapeutics Inc.July 2025 Short Interest & Short-Term High Return Strategies - Newser
What technical models suggest about Relay Therapeutics Inc.’s comebackWeekly Stock Analysis & Short-Term High Return Ideas - Newser
Will Relay Therapeutics Inc. see short term momentumGap Up & Weekly Setup with High ROI Potential - Newser
Using data tools to time your Relay Therapeutics Inc. exitJuly 2025 Patterns & Free Community Consensus Stock Picks - Newser
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Jul 28 '25 |
Sale |
3.74 |
1,359 |
5,083 |
393,722 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 29 '25 |
Sale |
3.68 |
18,380 |
67,638 |
335,295 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 28 '25 |
Sale |
3.74 |
1,701 |
6,362 |
353,675 |
| Bergstrom Donald A | President, R&D |
Jul 29 '25 |
Sale |
3.68 |
26,701 |
98,260 |
552,720 |
| Bergstrom Donald A | President, R&D |
Jul 28 '25 |
Sale |
3.74 |
4,069 |
15,218 |
579,421 |
| Adams Brian | Chief Legal Officer |
Jul 29 '25 |
Sale |
3.68 |
18,276 |
67,256 |
371,472 |
| Adams Brian | Chief Legal Officer |
Jul 28 '25 |
Sale |
3.74 |
1,637 |
6,122 |
389,748 |
| Patel Sanjiv | President and CEO |
Jul 09 '25 |
Sale |
3.57 |
61,379 |
219,123 |
765,288 |
| Rahmer Peter | See remarks |
Apr 30 '25 |
Sale |
3.00 |
10,739 |
32,217 |
390,081 |
| Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):